Alla Patlis
CIK: 0001639227
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Officer
Discretionary Trading P&L
Holdings
About Patlis Alla
Patlis Alla (SEC CIK 0001639227) files insider reports with the SEC as Officer of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 2 ownership filings by Patlis Alla, all Form 4s, filed between Jan 3, 2025 and May 29, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Patlis Alla's filings is in NEW YORK, NY.
Recent filings by Patlis Alla
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- ARBEL IRIT, Director
- Bairu Menghisteab, Director